microluton 30 mikrog tabletti, päällystetty
paranova oy - levonorgestrelum - tabletti, päällystetty - 30 mikrog - levonorgestreeli
microluton 30 mikrog tabletti, päällystetty
orifarm oy - levonorgestrelum - tabletti, päällystetty - 30 mikrog - levonorgestreeli
galieve 500 mg / 213 mg / 325 mg oraalisuspensio, annospussi
reckitt benckiser healthcare (scandinavia) a/s - calcium carbonate, sodium alginate, sodium bicarbonate - oraalisuspensio, annospussi - 500 mg / 213 mg / 325 mg - algiinihappo
comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - rokotteet - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. käyttö tämä rokote tulee virallisten suositusten mukaisesti.
relaxit peräpuikko
pfizer health ab - asolectin,natrii bicarbonas,kalii bitartras,calcii silicas - peräpuikko - hiilidioksidia muodostavat valmisteet
gaviscon jauhe
ferring ab - liuosta varten haihtua,natrii bicarbonas,happo alginicum - jauhe - algiinihappo
natr bicarbonas 1 g tabletti
schering oy - natrii hydrogenocarbonas - tabletti - 1 g - natriumbikarbonaattia sisältävät antasidit
natr bicarb 75 mg/ml infuusioneste
orion oyj - natrii hydrogenocarbonas - infuusioneste - 75 mg/ml - natriumbikarbonaatti
gaviscon annosjauhe
ferring ab - liuosta varten haihtua,happo alginicum,natrii bicarbonas - annosjauhe - algiinihappo
natr.bicarb. 75 mg/ml infuusioneste
fresenius kabi ab fresenius kabi ab - natrii hydrogenocarbonas - infuusioneste - 75 mg/ml - elektrolyytit